Avant and Johnson & Johnson are active in the diabetes treatment industry.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Avant and Johnson & Johnson are active in the diabetes treatment industry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Avant
company
Nothing else this week.
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- Johnson & Johnson and Recordati Industria Chimica E Farmaceutica are noted as large-cap healthcare companies.
- Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.
- JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.
- Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.
- Johnson & Johnson, BDX, and Universal Health Realty Income Trust were identified as attractive dividend-paying healthcare stocks.
Coverage
Newest first; wire copies grouped- CNW GroupArtificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity MarketNewsUpdates News Commentary NEW YORK, July 22, 2025 /CNW/ -- According to a